Trial Profile
A phase II trial of nivolumab in advanced mucosal melanoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Jan 2019
Price :
$35
*
At a glance
- Drugs Nivolumab (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- 07 Dec 2017 Status changed from recruiting to completed.
- 08 Dec 2014 New trial record